SCHEMBL28301558

SCHEMBL28301558

CC(O)C(C(=O)OC(C)(C)C)C(N)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 1/20 0.40
ADRA2C P18825 1/20 0.40
LMNA P02545 1/20 0.40
HIF1A Q16665 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ATM Q13315 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ALDH1A1 P00352 3/20 0.39
DPP4 P27487 2/20 0.38
AOC3 Q16853 1/20 0.38
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
MAPT P10636 2/20 0.38
RECQL P46063 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
AAK1 Q2M2I8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27660598 0.87 ATM (0.38) ADRA2AADRA2CLMNAHIF1AKDM4E
SCHEMBL5650824 0.87 ATM (0.38) ADRA2AADRA2CLMNAHIF1AKDM4E
SCHEMBL5652634 0.87 ATM (0.38) ADRA2AADRA2CLMNAHIF1AKDM4E
SCHEMBL6896070 0.84 DPP4 (0.43) ADRA2AADRA2CLMNAHIF1AKDM4E
SCHEMBL15630763 0.84 DPP4 (0.43) ADRA2AADRA2CLMNAHIF1AKDM4E
SCHEMBL27892297 0.83 AAK1 (0.36) ATML3MBTL1DPP4AOC3NPSR1
SCHEMBL14625079 0.83 KMT2A (0.53) ADRA2AADRA2CLMNAHIF1AKDM4E
SCHEMBL10699210 0.83 DPP4 (0.42) ADRA2AADRA2CLMNAHIF1AKDM4E
SCHEMBL1624875 0.81 DPP4 (0.48) ATML3MBTL1ALDH1A1DPP4AOC3
SCHEMBL9833387 0.80 ALDH1A1 (0.41) ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109943542-A A kind of alcohol dehydrogenase for the production of atazanavir intermediate 南京诺云生物科技有限公司 2019-06-28 CN disclosed
CN-109943577-A A kind of bioconversion method of anti-AIDS drug atazanavir intermediate 南京诺云生物科技有限公司 2019-06-28 CN disclosed